Pat Toomey: “Medicaid's growth rate is not on a sustainable path.”

I think there is a case to be made that there should be a regulatory regime on disclosure requirements for an issuer.

It is absolutely essential to investigate any fraud and violations of existing law, and prosecute those who are committing those crimes.

There was unauthorized lending of customer assets to an affiliated entity, and there were apparently fraudulent promises to investors and customers about FTX's operations.

I think that there are a number of ways that you can go about creating a regulatory regime to take account of that risk.